Megan comes to cc-TDI with four years of experience in the fields of muscle cell and molecular biology, specializing in both the muscle-related pediatric cancer rhabdomyosarcoma and acute myeloid and T-cell leukemia. Her formal education and previous laboratory training provides a strong background in murine muscle dissection and satellite cell/ myoblast isolation and tissue culture, skills which have proved invaluable for studying rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas (NRSTS). Megan is adept at performing in vitro molecular biology experiments and GEMM (genetically engineered mouse model) in vivo experiments, both of which are utilized by our laboratory. Megan’slong term research interests include understanding the influence of cell-of-origin on soft tissue sarcoma biology using conditional genetic mouse models.
Dr. Charles Keller, MD
Scientific Director
